← Back
$ASTH All transactions

Astrana Health, Inc.

F

$ Value

$50K

Shares

1,694

Price

$30

Filed

Sep 9

Insider

Name

Kumar Dinesh M.

Title

Chief Medical Officer

CIK

0001850439

Roles

Officer

Transaction Details

Transaction Date

2025-09-05

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

217,893

Footnotes

Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2025. | Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 56,754 shares, which will vest in two equal annual installments beginning on January 23, 2026; (ii) 13,464 shares, which will vest on January 1, 2026; and (iii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 23,364 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026. | Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0001104659-25-088645

Form Type

4

Issuer CIK

0001083446

Kumar Dinesh M.'s History

Date Ticker Type Value
2026-04-01 ASTH A $0
2026-04-01 ASTH F $1.4M
2026-03-05 ASTH F $43K
2026-01-23 ASTH F $292K
2026-01-01 ASTH F $127K
2025-09-05 ASTH F $50K
2025-07-01 ASTH F $171K
2025-06-04 ASTH F $41K
2025-04-29 ASTH F $26K

Other Insiders at ASTH (90d)

Insider Bought Sold Last
Lam Thomas S. 2026-04-06
Sim Kenneth T.
Executive Chairman
2026-04-06
Sim Brandon
CEO and President
2026-04-06
Kumar Dinesh M.
Chief Medical Officer
2026-04-01
Sobotka Glenn
Chief Accounting Officer
2026-03-26
Basho Chandan
COO and CFO
2026-04-14